Stock Track | Tilray Inc. Soars 5.51% in Pre-Market as Trump's Potential Marijuana Rescheduling Boosts Cannabis Sector

Stock Track12-18 17:56

Tilray Inc. (NASDAQ: TLRY) surged 5.51% in pre-market trading, reflecting heightened investor optimism in the cannabis sector. The rally follows reports that U.S. President Donald Trump is poised to sign an executive order rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act.

The move would lift the crippling IRS Section 280E tax burden, allowing cannabis companies to deduct standard business expenses and potentially achieve profitability for the first time. Investors are betting on the transformative impact of this regulatory change, which could also ease research restrictions and improve access to capital for the industry. Tilray, as a key player in the cannabis sector, stands to benefit significantly from these developments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment